EXACT Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . EXACT Sciences
EXAS Stock  USD 53.66  0.59  1.11%   
EXACT Sciences financial statements provide useful quarterly and yearly information to potential EXACT Sciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on EXACT Sciences financial statements helps investors assess EXACT Sciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting EXACT Sciences' valuation are summarized below:
Gross Profit
1.5 B
Profit Margin
(0.08)
Market Capitalization
9.8 B
Enterprise Value Revenue
4.268
Revenue
2.7 B
There are over one hundred nineteen available fundamental measures for EXACT Sciences, which can be analyzed over time and compared to other ratios. All traders should verify EXACT Sciences' latest fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 402.9 M in 2024. Enterprise Value is likely to gain to about 370.1 M in 2024

EXACT Sciences Total Revenue

2.62 Billion

Check EXACT Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EXACT Sciences' main balance sheet or income statement drivers, such as Interest Expense of 25.6 M, Other Operating Expenses of 2.9 B or Research Development of 447.2 M, as well as many indicators such as Price To Sales Ratio of 5.06, Dividend Yield of 0.0 or PTB Ratio of 4.47. EXACT financial statements analysis is a perfect complement when working with EXACT Sciences Valuation or Volatility modules.
  
Check out the analysis of EXACT Sciences Correlation against competitors.
For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.

EXACT Sciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets6.8 B6.5 B2.5 B
Slightly volatile
Total Stockholder Equity3.3 B3.1 B1.4 B
Slightly volatile
Cash635.6 M605.4 M261.6 M
Slightly volatile
Cash And Short Term Investments816.5 M777.6 M547.6 M
Slightly volatile
Common Stock Shares Outstanding189.2 M180.1 M112.8 M
Slightly volatile
Liabilities And Stockholders Equity6.8 B6.5 B2.5 B
Slightly volatile
Other Stockholder Equity6.9 B6.6 B2.7 B
Slightly volatile
Total Liabilities3.5 B3.3 B1.2 B
Slightly volatile
Total Current Assets1.3 B1.2 B708.4 M
Slightly volatile
Other Current Liabilities369.7 M352.1 M116.5 M
Slightly volatile
Total Current Liabilities540.4 M514.7 M207 M
Slightly volatile
Property Plant And Equipment Net884.2 M842.1 M328.4 M
Slightly volatile
Accounts Payable82.8 M78.8 M28.2 M
Slightly volatile
Non Current Assets Total5.5 B5.3 B1.8 B
Slightly volatile
Common Stock Total Equity2.1 M2 M1.2 M
Slightly volatile
Other Current Assets89.9 M85.6 M32.2 M
Slightly volatile
Property Plant And Equipment Gross1.3 B1.3 B385.4 M
Slightly volatile
Common Stock1.9 M1.8 M1.2 M
Slightly volatile
Property Plant Equipment826.8 M787.5 M293 M
Slightly volatile
Other Liabilities416.7 M396.8 M114.2 M
Slightly volatile
Short Term Investments222.6 M172.3 M290.5 M
Slightly volatile
Non Current Liabilities Total3 B2.8 B972.2 M
Slightly volatile
Current Deferred Revenue84.2 M76.9 M81.9 M
Slightly volatile
Short and Long Term Debt Total2.7 B2.6 B877.8 M
Slightly volatile
Long Term Debt2.4 B2.3 B799.3 M
Slightly volatile
Long Term Debt Total2.6 B2.5 B883.1 M
Slightly volatile
Capital Surpluse7.6 B7.3 B2.9 B
Slightly volatile
Non Current Liabilities Other352.8 M336 M106.9 M
Slightly volatile
Short Term Debt44.2 M83.8 M35.1 M
Slightly volatile
Net Receivables113 M203.6 M76.4 M
Slightly volatile
Short and Long Term Debt42.4 M57.5 M30.7 M
Slightly volatile
Net Invested Capital4.1 B5.5 B2.2 B
Slightly volatile
Long Term Investments2.4 M2.7 M2.9 M
Slightly volatile
Net Working Capital881.9 M679.7 M628.5 M
Slightly volatile
Capital Stock1.8 M1.8 M1.4 M
Slightly volatile
Capital Lease Obligations189.7 M190.4 M146.1 M
Slightly volatile

EXACT Sciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses2.9 B2.7 B1 B
Slightly volatile
Research Development447.2 M425.9 M176.5 M
Slightly volatile
Total Operating Expenses2.2 B2.1 B832.3 M
Slightly volatile
Depreciation And Amortization216.9 M206.6 M74.4 M
Slightly volatile
Selling General Administrative1.5 B1.4 B384.9 M
Slightly volatile
Total Revenue2.6 B2.5 B814.5 M
Slightly volatile
Selling And Marketing Expenses217.2 M203.9 M250.9 M
Slightly volatile
Interest Income29.5 M28.1 M12.3 M
Slightly volatile
Reconciled Depreciation131.5 M206.6 M71.8 M
Slightly volatile
Non Recurring13.7 M14.4 M158 M
Slightly volatile

EXACT Sciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow129.5 M242.8 M192.9 M
Slightly volatile
Other Cashflows From Financing Activities20.7 M21.8 M243.3 M
Pretty Stable
Depreciation216.9 M206.6 M72 M
Slightly volatile
Capital Expenditures130.4 M124.2 M74.8 M
Slightly volatile
Total Cash From Financing Activities200.6 M159.8 M300.8 M
Pretty Stable
End Period Cash Flow640.2 M609.7 M261.9 M
Slightly volatile
Stock Based Compensation242.9 M231.3 M96.6 M
Slightly volatile
Change To Netincome131.1 M208.5 M118.3 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio5.065.3313341
Slightly volatile
PTB Ratio4.474.23715.5678
Very volatile
Days Sales Outstanding28.2529.7317119
Slightly volatile
Book Value Per Share18.3317.459910.0326
Slightly volatile
Average Payables195.2 K350.5 K354.5 K
Very volatile
Stock Based Compensation To Revenue0.08790.09250.8446
Slightly volatile
Capex To Depreciation0.630.60112.5626
Slightly volatile
PB Ratio4.474.23715.5678
Very volatile
EV To Sales5.816.1111264
Slightly volatile
Inventory Turnover3.135.13243.1043
Slightly volatile
Days Of Inventory On Hand12871.1173177
Slightly volatile
Sales General And Administrative To Revenue0.540.566618.878
Slightly volatile
Research And Ddevelopement To Revenue0.160.170420.199
Slightly volatile
Capex To Revenue0.04720.04974.2075
Slightly volatile
Cash Per Share4.614.31685.1005
Very volatile
Intangibles To Total Assets0.690.65790.2696
Slightly volatile
Current Ratio2.22.32058.0602
Slightly volatile
Receivables Turnover7.0212.27646.6691
Slightly volatile
Graham Number12.4621.099719.5154
Slightly volatile
Shareholders Equity Per Share18.3317.459910.0326
Slightly volatile
Debt To Equity0.790.75170.3543
Slightly volatile
Capex Per Share0.720.68940.5351
Slightly volatile
Revenue Per Share14.5713.87654.9848
Slightly volatile
Interest Debt Per Share13.9213.25995.4009
Slightly volatile
Debt To Assets0.380.36530.1782
Slightly volatile
Operating Cycle199101299
Slightly volatile
Price Book Value Ratio4.474.23715.5678
Very volatile
Ebt Per Ebit0.890.93831.0639
Very volatile
Company Equity Multiplier1.162.05751.443
Slightly volatile
Long Term Debt To Capitalization0.450.42390.2045
Slightly volatile
Total Debt To Capitalization0.450.42910.2078
Slightly volatile
Debt Equity Ratio0.790.75170.3543
Slightly volatile
Quick Ratio1.972.07287.8763
Slightly volatile
Net Income Per E B T0.631.01190.9012
Slightly volatile
Cash Ratio1.121.17622.2158
Slightly volatile
Days Of Inventory Outstanding12871.1173177
Slightly volatile
Days Of Sales Outstanding28.2529.7317119
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.190.20451.3778
Very volatile
Price To Book Ratio4.474.23715.5678
Very volatile
Fixed Asset Turnover1.582.96861.7118
Slightly volatile
Debt Ratio0.380.36530.1782
Slightly volatile
Price Sales Ratio5.065.3313341
Slightly volatile
Asset Turnover0.410.38630.2118
Slightly volatile
Price Fair Value4.474.23715.5678
Very volatile

EXACT Sciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap402.9 M383.8 M394.6 M
Slightly volatile
Enterprise Value370.1 M352.5 M362.2 M
Slightly volatile

EXACT Fundamental Market Drivers

Forward Price Earnings2500
Cash And Short Term Investments777.6 M

EXACT Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About EXACT Sciences Financial Statements

EXACT Sciences shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although EXACT Sciences investors may analyze each financial statement separately, they are all interrelated. The changes in EXACT Sciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on EXACT Sciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue76.9 M84.2 M
Total Revenue2.5 B2.6 B
Cost Of Revenue654.2 M687 M
Stock Based Compensation To Revenue 0.09  0.09 
Sales General And Administrative To Revenue 0.57  0.54 
Research And Ddevelopement To Revenue 0.17  0.16 
Capex To Revenue 0.05  0.05 
Revenue Per Share 13.88  14.57 
Ebit Per Revenue(0.09)(0.09)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for EXACT Stock Analysis

When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY